US Stock MarketDetailed Quotes

DYN Dyne Therapeutics

Watchlist

27.680
-1.070-3.72%

Close May 17 16:00 ET

27.760
+0.080+0.29%

Post 19:43 ET

2.42BMarket Cap-6954P/E (TTM)

Dyne Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

(Q2)Jun 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-67.43%-78.54M

-22.46%-188.16M

-19.92%-35.01M

-18.22%-50.6M

-80.02%-55.64M

7.55%-46.91M

-28.51%-153.65M

-4.00%-29.19M

-58.82%-42.81M

33.02%-30.91M

Net income from continuing operations

-48.57%-65.65M

-40.36%-235.94M

-71.63%-66.64M

-45.49%-60.21M

-24.09%-64.9M

-24.18%-44.19M

-12.60%-168.1M

25.02%-38.83M

2.81%-41.39M

-74.61%-52.3M

Operating gains losses

-101.42%-2K

314.71%141K

--0

370.00%141K

325.00%34K

--4K

--9K

---9K

Depreciation and amortization

-6.31%386K

-0.59%1.67M

-0.50%399K

8.56%431K

-6.30%431K

-3.06%412K

54.69%1.68M

17.60%401K

52.69%397K

84.74%460K

Other non cash items

-18.01%173K

-52.59%788K

-21.50%168K

122.59%166K

-78.72%243K

-79.73%211K

322.79%1.66M

129.81%214K

-5,553.85%-735K

14,375.00%1.14M

Change In working capital

-314.44%-32.83M

589.07%26.31M

395.13%25.53M

187.29%4.5M

-74.34%4.2M

63.57%-7.92M

-158.11%-5.38M

-70.26%5.16M

-146.66%-5.16M

176.73%16.37M

-Change in prepaid assets

-192.81%-4.07M

180.53%3.34M

707.45%4.12M

-23.96%-4.96M

-62.45%5.57M

91.02%-1.39M

-175.17%-4.14M

-95.49%510K

-146.61%-4M

168.22%14.82M

-Change in payables and accrued expense

-340.33%-28.76M

1,959.92%22.97M

360.85%21.41M

917.29%9.46M

-188.47%-1.37M

-4.20%-6.53M

-109.01%-1.24M

-22.91%4.65M

-123.94%-1.16M

58.68%1.54M

Cash from discontinued investing activities

Operating cash flow

-67.43%-78.54M

-22.46%-188.16M

-19.92%-35.01M

-18.22%-50.6M

-80.02%-55.64M

7.55%-46.91M

-28.51%-153.65M

-4.00%-29.19M

-58.82%-42.81M

33.02%-30.91M

Investing cash flow

Cash flow from continuing investing activities

-764.54%-179.84M

-4.46%83.31M

36.18%26.2M

-75.18%12.82M

-6.57%17.23M

1,366.95%27.06M

163.24%87.2M

8,285.96%19.24M

1,913.83%51.66M

386.65%18.44M

Net PPE purchase and sale

16.96%-191K

76.23%-729K

84.20%-82K

81.15%-167K

4.21%-250K

83.58%-230K

15.23%-3.07M

73.92%-519K

-0.57%-886K

64.63%-261K

Net investment purchase and sale

-758.24%-179.65M

-6.90%84.04M

33.01%26.28M

-75.28%12.99M

-6.53%17.48M

3,813.20%27.29M

167.23%90.27M

1,025.70%19.76M

2,771.28%52.54M

428.37%18.7M

Cash from discontinued investing activities

Investing cash flow

-764.54%-179.84M

-4.46%83.31M

36.18%26.2M

-75.18%12.82M

-6.57%17.23M

1,366.95%27.06M

163.24%87.2M

8,285.96%19.24M

1,913.83%51.66M

386.65%18.44M

Financing cash flow

Cash flow from continuing financing activities

1,317.28%408.39M

45.28%54.32M

-99.60%147K

548.57%454K

25,057.58%24.91M

159,983.33%28.82M

-76.31%37.39M

41,701.12%37.2M

-84.68%70K

296.00%99K

Net common stock issuance

1,308.08%397.47M

42.07%52.37M

-100.00%-1K

--0

--24.14M

--28.23M

-76.56%36.86M

--36.86M

--0

Proceeds from stock option exercised by employees

1,759.63%10.92M

269.19%1.95M

-56.73%148K

548.57%454K

671.72%764K

3,161.11%587K

-9.42%529K

284.27%342K

-84.68%70K

296.00%99K

Cash from discontinued financing activities

Financing cash flow

1,317.28%408.39M

45.28%54.32M

-99.60%147K

548.57%454K

25,057.58%24.91M

159,983.33%28.82M

-76.31%37.39M

41,701.12%37.2M

-84.68%70K

296.00%99K

Net cash flow

Beginning cash position

-28.96%123.94M

-14.28%174.47M

-9.93%132.6M

22.88%169.93M

21.75%183.44M

-14.28%174.47M

-32.87%203.52M

-36.47%147.22M

-47.03%138.3M

-51.96%150.66M

Current changes in cash

1,572.58%150.01M

-73.91%-50.53M

-131.79%-8.66M

-518.32%-37.33M

-9.19%-13.5M

116.97%8.97M

70.84%-29.05M

196.58%27.25M

130.41%8.92M

76.47%-12.37M

End cash Position

49.35%273.96M

-28.96%123.94M

-9.93%132.6M

22.88%169.93M

21.75%183.44M

-14.28%174.47M

-36.47%147.22M

-47.03%138.3M

Free cash flow

-67.02%-78.73M

-20.53%-188.89M

-18.10%-35.09M

-16.20%-50.77M

-79.31%-55.89M

9.59%-47.14M

-27.22%-156.71M

1.15%-29.71M

-56.98%-43.69M

33.52%-31.17M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022	(Q2)Jun 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-67.43%-78.54M	-22.46%-188.16M	-19.92%-35.01M	-18.22%-50.6M	-80.02%-55.64M	7.55%-46.91M	-28.51%-153.65M	-4.00%-29.19M	-58.82%-42.81M	33.02%-30.91M
Net income from continuing operations	-48.57%-65.65M	-40.36%-235.94M	-71.63%-66.64M	-45.49%-60.21M	-24.09%-64.9M	-24.18%-44.19M	-12.60%-168.1M	25.02%-38.83M	2.81%-41.39M	-74.61%-52.3M
Operating gains losses	-101.42%-2K	314.71%141K	--0	--0	--0	370.00%141K	325.00%34K	--4K	--9K	---9K
Depreciation and amortization	-6.31%386K	-0.59%1.67M	-0.50%399K	8.56%431K	-6.30%431K	-3.06%412K	54.69%1.68M	17.60%401K	52.69%397K	84.74%460K
Other non cash items	-18.01%173K	-52.59%788K	-21.50%168K	122.59%166K	-78.72%243K	-79.73%211K	322.79%1.66M	129.81%214K	-5,553.85%-735K	14,375.00%1.14M
Change In working capital	-314.44%-32.83M	589.07%26.31M	395.13%25.53M	187.29%4.5M	-74.34%4.2M	63.57%-7.92M	-158.11%-5.38M	-70.26%5.16M	-146.66%-5.16M	176.73%16.37M
-Change in prepaid assets	-192.81%-4.07M	180.53%3.34M	707.45%4.12M	-23.96%-4.96M	-62.45%5.57M	91.02%-1.39M	-175.17%-4.14M	-95.49%510K	-146.61%-4M	168.22%14.82M
-Change in payables and accrued expense	-340.33%-28.76M	1,959.92%22.97M	360.85%21.41M	917.29%9.46M	-188.47%-1.37M	-4.20%-6.53M	-109.01%-1.24M	-22.91%4.65M	-123.94%-1.16M	58.68%1.54M
Cash from discontinued investing activities
Operating cash flow	-67.43%-78.54M	-22.46%-188.16M	-19.92%-35.01M	-18.22%-50.6M	-80.02%-55.64M	7.55%-46.91M	-28.51%-153.65M	-4.00%-29.19M	-58.82%-42.81M	33.02%-30.91M
Investing cash flow
Cash flow from continuing investing activities	-764.54%-179.84M	-4.46%83.31M	36.18%26.2M	-75.18%12.82M	-6.57%17.23M	1,366.95%27.06M	163.24%87.2M	8,285.96%19.24M	1,913.83%51.66M	386.65%18.44M
Net PPE purchase and sale	16.96%-191K	76.23%-729K	84.20%-82K	81.15%-167K	4.21%-250K	83.58%-230K	15.23%-3.07M	73.92%-519K	-0.57%-886K	64.63%-261K
Net investment purchase and sale	-758.24%-179.65M	-6.90%84.04M	33.01%26.28M	-75.28%12.99M	-6.53%17.48M	3,813.20%27.29M	167.23%90.27M	1,025.70%19.76M	2,771.28%52.54M	428.37%18.7M
Cash from discontinued investing activities
Investing cash flow	-764.54%-179.84M	-4.46%83.31M	36.18%26.2M	-75.18%12.82M	-6.57%17.23M	1,366.95%27.06M	163.24%87.2M	8,285.96%19.24M	1,913.83%51.66M	386.65%18.44M
Financing cash flow
Cash flow from continuing financing activities	1,317.28%408.39M	45.28%54.32M	-99.60%147K	548.57%454K	25,057.58%24.91M	159,983.33%28.82M	-76.31%37.39M	41,701.12%37.2M	-84.68%70K	296.00%99K
Net common stock issuance	1,308.08%397.47M	42.07%52.37M	-100.00%-1K	--0	--24.14M	--28.23M	-76.56%36.86M	--36.86M	--0	--0
Proceeds from stock option exercised by employees	1,759.63%10.92M	269.19%1.95M	-56.73%148K	548.57%454K	671.72%764K	3,161.11%587K	-9.42%529K	284.27%342K	-84.68%70K	296.00%99K
Cash from discontinued financing activities
Financing cash flow	1,317.28%408.39M	45.28%54.32M	-99.60%147K	548.57%454K	25,057.58%24.91M	159,983.33%28.82M	-76.31%37.39M	41,701.12%37.2M	-84.68%70K	296.00%99K
Net cash flow
Beginning cash position	-28.96%123.94M	-14.28%174.47M	-9.93%132.6M	22.88%169.93M	21.75%183.44M	-14.28%174.47M	-32.87%203.52M	-36.47%147.22M	-47.03%138.3M	-51.96%150.66M
Current changes in cash	1,572.58%150.01M	-73.91%-50.53M	-131.79%-8.66M	-518.32%-37.33M	-9.19%-13.5M	116.97%8.97M	70.84%-29.05M	196.58%27.25M	130.41%8.92M	76.47%-12.37M
End cash Position	49.35%273.96M	-28.96%123.94M	-28.96%123.94M	-9.93%132.6M	22.88%169.93M	21.75%183.44M	-14.28%174.47M	-14.28%174.47M	-36.47%147.22M	-47.03%138.3M
Free cash flow	-67.02%-78.73M	-20.53%-188.89M	-18.10%-35.09M	-16.20%-50.77M	-79.31%-55.89M	9.59%-47.14M	-27.22%-156.71M	1.15%-29.71M	-56.98%-43.69M	33.52%-31.17M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall